ENGAGE THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 25 Jul 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86588727
- Registration number
- 5655985
- Mark type
- Stylized text
- Filed
- 06 Apr 2015
- Published for opposition
- 29 Sept 2015
- Registered
- 15 Jan 2019
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders
Owner
- ENGAGE THERAPEUTICS, INC., SUMMIT, NJ, US
- ENGAGE THERAPEUTICS, INC., SUMMIT, NJ, US
- Alexza Pharmaceuticals, Inc., Mountain View, CA, US
- Alexza Pharmaceuticals, Inc., Mountain View, CA, US
Prosecution history
- 25 Jul 2025 — CANCELLED SEC. 8 (6-YR)
- 11 Apr 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 08 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Dec 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Nov 2018 — USE AMENDMENT FILED
- 09 Nov 2018 — TEAS STATEMENT OF USE RECEIVED
- 26 May 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED